Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Germany Clear all

107 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20023
20031
20043
20054
20062
20075
20081
20094
20102
20114
20126
20134
20146
20153
20161
20175
20185
20195
20201
202110
20226
20232
20243
20257
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Terminated22
Recruiting16
Active, not recruiting15
Unknown status6
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca13
Eli Lilly and Company8
Pfizer6
Novartis Pharmaceuticals5
Sanofi5
European Organisation for Research and Treatment of Cancer - EORTC4
AbbVie3
AIO-Studien-gGmbH2
BeiGene2
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis107
Breast Neoplasms23
Neoplasms19
Carcinoma, Non-Small-Cell Lung13
Melanoma11
Colorectal Neoplasms10
Prostatic Neoplasms8
Carcinoma6
Brain Neoplasms5
Carcinoma, Renal Cell5

Trials

Showing 1 to 25 of 107. Each trial links to its page on Pharma Observatory.

7 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.